Skip to main content
Eric Tuday, MD, PhD

Eric C. Tuday, M.D., Ph.D.

Assistant Professor & Cardiologist
Cardiovascular Medicine Division
Internal Medicine Department
School of Medicine
University of Utah

Dr. Tuday is a physician-scientist with a primary focus on vascular health and aging. His expertise is in basic, translational, and clinical cardiac, vascular and aging research. Additionally, he has training in healthcare quality, safety, and efficiency methods/research/implementation. Currently an Assistant Professor of Medicine in the Division of Cardiovascular medicine, Dr. Tuday is part of the Translational Vascular Physiology (TVP) Laboratory that is centered at the Salt Lake City Veterans Affairs Hospital Geriatric Research Education and Clinical Center (GRECC). 


30 N Medical Drive, Room 4A100


Fellow   Johns Hopkins Medicine (Cardiology), 2015-2019
Resident Virginia Mason Medical Center (Internal Medicine), 2012-2015
M.D. Northwestern University Feinberg School of Medicine (Medicine), 2008-2012
Ph.D.  Johns Hopkins University School of Medicine (Biomedical Engineering), 2004-2009
M.S.  University of Utah (Biomedical Engineering), 2003-2004
B.S. University of Utah (Biomedical Engineering), 2000-2003


Clinical Expertise General cardiology and echocardiography
Research Interests Cardiac and vascular molecular and cellular contributors to abnormal aging via active and passive mechanics and function
Hobbies Running with his two dogs, kayaking/paddle boarding, hiking, and skiing
Hometown Roy, Utah


Dr. Tuday completed his B.S. and M.S. at the University of Utah in the Department of Biomedical Engineering investigating unidirectional action potentials in peripheral nerves. His primary research mentor was Dr. Ken Horch and career mentors included Drs. Doug Christensen and Rob MacLeod. 

Dr. Tuday was then accepted to the Ph.D. program in biomedical engineering at Johns Hopkins University. His primary mentors there were Drs. Artin Shoukas and Dan Berkowitz. He studied the effects of spaceflight on aortic stiffness and orthostatic intolerance. He also seized the opportunity to learn experimental methods and assimilate knowledge related to endothelial cell, smooth muscle cell, and arterial health. 

Following his Ph.D., Dr. Tuday found his experience working with human subjects during his spaceflight studies extremely rewarding and ultimately wanted to contribute to the overall mission of improving human health. This lead him to apply for medical school and was ultimately accepted a position at Northwestern Feinberg School of Medicine.

While studying medicine, Dr. Tuday also engaged in clinical research and published one of the first TAVR-related clinical studies in the nation.

Following medical school, Dr. Tuday was fortunate to match at Virginia Mason Medical Center in Seattle, WA for medicine residency. There he thrived and embraced systemic quality control and improvement methods and research. His work and study was recognized by certification by a Japanese Sensei in the art of production and systems management. Upon completion of his medicine residency he applied to Johns Hopkins University for cardiology training and was ultimately accepted.

Upon his return to Johns Hopkins, Dr. Tuday sought to expand his research aims, while also completing a cardiovascular medicine fellowship. He continued to work with his primary mentor, Dr. Berkowitz while also seeking out additional mentorship with Drs. Sam Das and Jay Baraban. Together, we researched the role of microRNAs in the development of vascular stiffness. This has formed the basis for his most recent publications and ultimately his current successful funding from the National Institute on Aging.

Having completed his fellowship, Dr. Tuday took a joint position as a tenure track physician-scientist with the SLC VA GRECC and the University of Utah to continue to investigate the pathophysiology and interventions upon detrimental large artery stiffness with aging in both animal and human models.